NEURO62

Presentation information

Symposium

[S-35] Symposium 35 Disassemble "CIDP"! Reclassification of "CIDP" based on molecular autoimmune mechanism

Fri. May 21, 2021 2:40 PM - 4:40 PM Room 07 (ICC Kyoto 1F Room D)

Chair:Koike Haruki(Department of Neurology, Nagoya University Graduate School of Medicine),Yamasaki Ryo(Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University)

[S-35-1] CIDP pathophysiology: a roadmap for future research

Luis Querol1,2 (1.Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2.Centro para la Investigacion en Red en Enfermedades Raras - CIBERER, Spain)

photo
Luis Querol (Valencia, 1980) graduated in Medicine at the University of Oviedo. He completed his residency in Neurology at the Santa Creu i Sant Pau Hospital in Barcelona. In 2009 started his Neuroimmunology fellowship in the group of Prof. Isabel Illa and in 2012, joined the group of Dr. Kevin O'Connor, Department of Neurology, Yale University (USA), where he developed projects related to autoantibodies in multiple sclerosis and myasthenia gravis.
Supervised by Prof Illa, he completed his PhD in Medicine at the Universidad Autónoma de Barcelona in 2013 thanks to studies that identified clinically useful antibodies in autoimmune neuropathies. In particular, these studies describe anti-contactin antibodies in a specific subgroup of CIDP patients.
He is currently appointed principal investigator for the Autoimmune Neurology Program of the ERN-NMD Neuromuscular Sant Pau. Luis Querol received the Best Young Clinical Researcher 2013 Award from CIBERNED, the PK Thomas Award at the European Federation of Neurological Societies in 2014, the Grifols Institute's SPIN Award (2016), the Oscar award of the AQuAS agency of Catalonia (2017) and the Scientific Award for Neuromuscular Diseases of the Spanish Society of Neurology (2019), all of them for his work with autoantibodies in CIDP.

Abstract password authentication.
Password is written on a pocket program and name badge.

Password